Paper · 40257501
Increased thermal stability of FGF10 leads to ectopic signaling during development.
Czyrek AA and 34 others. Cell Mol Life Sci, 2025. Cited by 5 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Increased thermal stability of FGF10 leads to ectopic signaling during development. Papers, record 40257501. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40257501
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fibroblast Growth Factor 10 | Major topic |
| Signal Transduction | Major topic |
| Animals | |
| Mice | |
| Humans | |
| Protein Stability | |
| Lung | |
| Receptors, Fibroblast Growth Factor |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References100
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,328,066 | Elucidating Fibroblast Growth Factor-Induced Kinome Dynamics Using Targeted Mass Spectrometry and Dynamic Modeling. | Mol Cell Proteomics | 2023 | https://conductscience.org/library/papers/37328066 | PubMed |
| 2 | 32,127,497 | FGF9 and FGF10 activate distinct signaling pathways to direct lung epithelial specification and branching. | Sci Signal | 2020 | https://conductscience.org/library/papers/32127497 | PubMed |
| 3 | 17,570,396 | Spackling the crack: stabilizing human fibroblast growth factor-1 by targeting the N and C terminus beta-strand interactions. | J Mol Biol | 2007 | https://conductscience.org/library/papers/17570396 | PubMed |
| 4 | 9,435,295 | Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. | Development | 1998 | https://conductscience.org/library/papers/9435295 | PubMed |
| 5 | 16,597,617 | Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. | J Biol Chem | 2006 | https://conductscience.org/library/papers/16597617 | PubMed |
| 6 | 26,529,612 | FireProt: Energy- and Evolution-Based Computational Design of Thermostable Multiple-Point Mutants. | PLoS Comput Biol | 2015 | https://conductscience.org/library/papers/26529612 | PubMed |
| 7 | 17,094,125 | Effect of polyanions on the structure and stability of repifermin (keratinocyte growth factor-2). | J Pharm Sci | 2007 | https://conductscience.org/library/papers/17094125 | PubMed |
| 8 | 37,509,496 | FGF1 Protects MCF-7 Cells against Taltobulin through Both the MEKs/ERKs and PI3K/AKT Signaling Pathway. | Biomedicines | 2023 | https://conductscience.org/library/papers/37509496 | PubMed |
| 9 | 19,410,332 | Negative regulation of fibroblast growth factor 10 (FGF-10) by polyoma enhancer activator 3 (PEA3). | Eur J Cell Biol | 2009 | https://conductscience.org/library/papers/19410332 | PubMed |
| 10 | 37,920,818 | Computer-assisted stabilization of fibroblast growth factor FGF-18. | Comput Struct Biotechnol J | 2023 | https://conductscience.org/library/papers/37920818 | PubMed |
1 to 10 of 100
See all 100 referencesCited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,542,977 | Mechanisms and Manifestations of Ligand Bias in Signaling: Focus on Receptor Tyrosine Kinases. | Chem Rev | 2026 | https://conductscience.org/library/papers/42542977 | PubMed |
| 42,439,993 | Advances in bovine oocyte in vitro maturation: mechanisms and strategies. | Vet Res Commun | 2026 | https://conductscience.org/library/papers/42439993 | PubMed |
| 42,387,574 | Structure-function relationship in FGF signaling: rational design of highly stable FGF2 variants and their effect on cell growth, metabolism, and survival. | J Biol Eng | 2026 | https://conductscience.org/library/papers/42387574 | PubMed |
| 41,520,078 | Engineered fibroblast growth factor 1 variants uncouple glucose-lowering effects from mitogenic activity with therapeutic potential for type 2 diabetes. | Mol Biomed | 2026 | https://conductscience.org/library/papers/41520078 | PubMed |
| 40,862,735 | Fibroblast Growth Factors in Lung Development and Regeneration: Mechanisms and Therapeutic Potential. | Cells | 2025 | https://conductscience.org/library/papers/40862735 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGF10 | 2,255 | PubTator's text mining | https://conductscience.org/library/genes/2255 | NCBI Gene |
| STAB1 | 23,166 | PubTator's text mining | https://conductscience.org/library/genes/23166 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40257501
GET https://conductscience.org/api/papers/v1/40257501/authors?page=2